HIMS
Hims Hers Health Inc
30.90$
+10.2%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 60.5% | 60.1% | 58.4% | 60.5% | 54.2% | 55.9% | 50.1% | 72.2% | 37.8% | 35.6% | 46.1% | 38.2% | |
| 14.0% | 21.9% | 23.5% | 26.9% | 27.5% | 31.2% | 30.7% | 59.9% | 15.5% | 10.6% | 9.8% | 16.8% | |
| 51.3% | 50.1% | 45.4% | 47.3% | 42.2% | 42.4% | 36.2% | 61.0% | 28.2% | 26.8% | 33.1% | 23.2% | |
| 1.0% | 1.5% | 1.4% | 1.2% | 0.8% | 0.9% | 0.8% | 0.4% | 1.9% | 1.5% | 6.6% | 10.3% | |
| 5.3% | 5.1% | 6.7% | 8.4% | 8.2% | 9.1% | 8.5% | 7.6% | 4.7% | 5.4% | 3.7% | 2.4% | |
| 7.9% | – | – | – | – | – | – | – | – | – | – | – | |
| 26.8% | 25.1% | 24.7% | 23.1% | 18.7% | 15.9% | 13.2% | 6.3% | 11.6% | 12.9% | 15.1% | 30.4% | |
| 4.7% | 4.2% | 4.0% | 3.6% | 7.4% | 6.1% | 4.9% | 2.2% | 8.7% | 9.1% | 11.5% | 11.7% | |
| 20.6% | 22.0% | 23.1% | 24.7% | 26.9% | 32.6% | 38.4% | 70.0% | 74.0% | 74.9% | 80.3% | 91.1% | |
| 19.9% | 20.1% | 20.8% | 22.6% | 25.3% | 31.3% | 31.4% | 14.5% | 20.2% | 18.8% | 27.3% | 40.9% | |
| 0.5% | 0.3% | 0.3% | 0.3% | 0.3% | 0.3% | 0.4% | 0.2% | 0.2% | 0.2% | 0.2% | 0.3% | |
| 10.1% | 9.8% | 9.8% | 11.9% | 12.5% | 12.9% | 12.2% | 5.6% | 8.9% | 6.6% | 13.5% | 13.8% | |
| – | – | – | – | – | – | – | 51.6% | 43.5% | 45.1% | 43.0% | 37.6% | |
| 79.4% | 78.0% | 76.9% | 75.3% | 73.1% | 67.4% | 61.6% | 30.0% | 26.0% | 25.1% | 19.7% | 8.9% | |
| -89.3% | -83.5% | -79.7% | -71.5% | -44.5% | -34.2% | -21.6% | -8.0% | -6.0% | -5.3% | -9.1% | -8.1% | |
| 50.8% | 47.5% | 51.2% | 48.9% | 39.0% | 34.0% | 27.7% | 13.7% | 11.1% | 11.5% | 10.1% | 6.4% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.